Last reviewed · How we verify
NCT06761807
Electrocardiographic and Electrophysiologic Changes After Percutaneous Closure of Atrial Septal Defect
NA trial testing Electrophysiology study of heart in ASD in 65 participants. Not yet recruiting.
2 November 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 65 |
| Start date | 20 January 2025 |
| Primary completion | 2 November 2026 |
| Estimated completion | 2 November 2027 |
Drugs / interventions tested
- Electrophysiology study of heart
Conditions studied
- ASD — all drugs for ASD →
- Brady Arrythmia — all drugs for Brady Arrythmia →
Sponsor
Assiut University
Who can join
18 and older, any sex, with ASD or Brady Arrythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary outcomes : Determining the incidence of SAN and AVN dysfunction before and after percutaneous ASD closure Comparing ECG and EP parameters of SAN and AVN before and after percutaneous ASD closure Secondary outcomes : Assessing clinical, echocardiographic and procedural risk factors affecting the AVN function after ASD closure device implantation Determining the incidence of supraventricular arrhythmia inducibility before and after percutaneous ASD closure
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06761807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ASD
Currently open trials in the same condition.
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07400484 — Differences in N-CAD Concentration and Brain Function Between Children With ASD and TD · recruiting
- NCT06670040 — Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder · NA · active not recruiting
- NCT04899544 — Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism · NA · recruiting
- NCT06012903 — Lower Urinary Tract Symptoms and School Functioning in Children · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06761807 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 7 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing